newsfilter
← Latest News
GlobeNewswire·

Cerevel Therapeutics to Present at the Stifel 4th Annual CNS Day Event

CAMBRIDGE, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (NASDAQ:CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that chairperson and chief executive officer, Tony Coles,